Key Metrics
0.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
Q4
Pharmacology (medical)
SJR
- Q4 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.19
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Migraine
- Familial Mediterranean fever
- Atopic dermatitis
- Burden of disease
- Middle East
- Constipation
- Sterility testing
- Type 2 diabetes
- Polypharmacy
- Systematic review
- Psoriatic arthritis
- Pulmonary hypertension
- Potentially Inappropriate Medications
- Ketoconazole
- Intensive care unit
- Rheumatoid arthritis
- Prison
- Randomized controlled trial
- Cabozantinib
- Fluticasone
Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1993 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Drugs and Therapy Perspectives ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Get on top of gout with a fresh look at treatment options
- 4 Apr 24
- Drugs & Therapy Perspectives
-
Full paper
Sparsentan in immunoglobulin A nephropathy: a profile of its use
- 29 Mar 24
- Drugs & Therapy Perspectives
-
Full paper
Treating paediatric Crohn’s disease is challenging but new treatments hold promise
- 28 Mar 24
- Drugs & Therapy Perspectives
-
Full paper
What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings?
- 28 Mar 24
- Drugs & Therapy Perspectives
-
Full paper
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
- 21 Mar 24
- Drugs & Therapy Perspectives
-
Full paper
Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins
- 21 Mar 24
- Drugs & Therapy Perspectives
Scite analysis
Powered by scite_
3.4k articles received 1.9k citations see all
- 86 Supporting
- 1,655 Mentioning
- 27 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 64 Corrections
- 17 Errata
- 0 Expression of Concern
FAQs
How long has Drugs and Therapy Perspectives been actively publishing?
Drugs and Therapy Perspectives has been in operation since 1993 till date.
What is the publishing frequency of Drugs and Therapy Perspectives ?
Drugs and Therapy Perspectives published with a Monthly frequency.
How many articles did Drugs and Therapy Perspectives publish last years ?
In 2023, Drugs and Therapy Perspectives published 64 articles.
What is the eISSN & pISSN for Drugs and Therapy Perspectives ?
For Drugs and Therapy Perspectives,eISSN is 1179-1977 and pISSN is1172-0360.
What is Citescore for Drugs and Therapy Perspectives ?
Citescore for Drugs and Therapy Perspectives is 0.9.
What is SNIP score for Drugs and Therapy Perspectives ?
SNIP score for Drugs and Therapy Perspectives is 0.19.
What is the SJR for Drugs and Therapy Perspectives ?
SJR for Drugs and Therapy Perspectives is Q4.
Who is the publisher of Drugs and Therapy Perspectives ?
SPRINGERNATURE is the publisher of Drugs and Therapy Perspectives.